Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539110 | SCV000634536 | benign | Stormorken syndrome; Combined immunodeficiency due to STIM1 deficiency; Myopathy with tubular aggregates | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001281025 | SCV001468439 | uncertain significance | Myopathy, tubular aggregate, 1; Stormorken syndrome; Combined immunodeficiency due to STIM1 deficiency | 2021-03-30 | criteria provided, single submitter | clinical testing | STIM1 NM_001277961.1 exon 11 p.Ala610Thr (c.1828G>A): This variant has been reported in the literature in 1 individual with cutaneous bruising with clinical suspicion for thrombocytopenia of unknown etiology, segregating with disease in 1 affected family member. However, both of these individuals also carried an additional variant of potential clinical significance in a different gene (GFI1B c.814+1G>A) (Johnson 2016 PMID:27479822). This variant is present in 0.2% (202/68194) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-4108060-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:461722). This variant amino acid Threonine (Thr) is present in several species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Computational predictive tools for this variant are limited or unavailable. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Gene |
RCV001591217 | SCV001825856 | uncertain significance | not provided | 2021-02-12 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Identified in two related patients with inherited thrombocytopenia, although these patients had a variant in the GFI1B gene that may have also contributed to the phenotype (Johnson et al., 2016); This variant is associated with the following publications: (PMID: 27479822) |
Ce |
RCV001591217 | SCV004133966 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | STIM1: BP4, BS2 |
Prevention |
RCV003925620 | SCV004746273 | likely benign | STIM1-related disorder | 2022-02-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |